Dr. Andres Braun joins TrovaGene, Inc.

Dr. Braun joins TrovaGene, Inc., as its vice president and chief medical officer. Dr. Braun has more than 25 years of direct industry experience in the development of molecular diagnostic assays for the clinical reference laboratory.

“I am excited about the opportunity that exists with TrovaGene. It’s extensive IP portfolio for transrenal molecular testing is unique and provides an excellent foundation from which to develop and provide assays for personalized medicine in the fields of cancer and infectious diseases”, Dr. Braun said.

Dr. Braun will lead the K-ras development team at TrovaGene, Inc., and will provide valuable leadership in the presentation of innovative applications of transrenal molecular diagnostics. Dr. Braun will also play a key role in the company's spearheading of research and new market development efforts.

Prior to joining TrovaGene, Inc., Dr. Braun was the director of scientific affairs at Sysmex America, Inc., from 2007 to 2009. Before that, he served as the founder and president of DX Innovations, Inc., which is a market research company focused on providing technical solutions for companies in the molecular diagnostics marketplace.

Additionally, Dr. Braun worked at Sequenom, Inc., from 1995 through 2005 as a laboratory director, director of research and development, vice president of research and development and chief medical officer.